These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 14628106)

  • 1. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
    Nguyen QV; Kälin A; Drouve U; Casez JP; Jaeger P
    Kidney Int; 2001 Jun; 59(6):2273-81. PubMed ID: 11380831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P; Monsour C; Canales BK
    Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism.
    Lumeng L; Lui A; Li TK
    J Clin Invest; 1980 Oct; 66(4):688-95. PubMed ID: 7419716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
    Hatch M
    Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1).
    Edwards P; Rose GA
    Urol Int; 1991; 47(3):113-7. PubMed ID: 1771698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
    Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between some lithogenetic factors and vitamin B6-status in idiopathic calcium lithiasis.
    Tolomelli B; Caudarella R; Rizzoli E; Marchetti M
    Int J Vitam Nutr Res; 1991; 61(4):304-9. PubMed ID: 1806534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validated UPLC-MS/MS method for the analysis of vitamin B
    Rossmann J; Christ S; Richter S; Friedrich Garbade S; Friedrich Hoffmann G; Opladen T; Günther Okun J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Dec; 1212():123503. PubMed ID: 36279779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronutrient status, with special reference to vitamin B6.
    Brussaard JH; Löwik MR; van den Berg H; Brants HA; Kistemaker C
    Eur J Clin Nutr; 1997 Nov; 51 Suppl 3():S32-8. PubMed ID: 9598766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A; Ayiomamitis A; Grass L; Oreopoulos DG
    Int Urol Nephrol; 1988; 20(4):353-9. PubMed ID: 3170105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible link between vitamin D and hyperoxaluria in patients with renal stone disease.
    Giannini S; Nobile M; Castrignano R; Pati T; Tasca A; Villi G; Pellegrini F; D'Angelo A
    Clin Sci (Lond); 1993 Jan; 84(1):51-4. PubMed ID: 8382134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contents of all forms of vitamin B6, pyridoxine-β-glucoside and 4-pyridoxic acid in mature milk of Japanese women according to 4-pyridoxolactone-conversion high performance liquid chromatography.
    Yagi T; Iwamoto S; Mizuseki R; Furuya M; Nakayama K
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(1):9-15. PubMed ID: 23535534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers.
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Am J Nephrol; 1985; 5(1):40-4. PubMed ID: 3970077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of magnesium oxide or citrate supplements on metabolic risk factors in kidney stone formers with idiopathic hyperoxaluria: a randomized clinical trial.
    Taheri M; Jalali S; Borumandnia N; Tavasoli S; Basiri A; Taheri F
    Magnes Res; 2024 Jul; 37(1):12-21. PubMed ID: 39077820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.